Space Pharmaceuticals completes Series A financing to advance AI-driven drug discovery
Space Pharmaceuticals, an AI-driven chemical space drug discovery company based in Basel, Switzerland, announced the completion of a Series A financing round of CHF 12 million, led by Venture Capital firm Cowin Capital. Spinned-off from 20 years of computational chemistry research from Prof. Jean-Louis Reymond, University of Bern, Switzerland, Space Pharmaceuticals’ GDBspace drug discovery engine […]